Is MRSN or XYLD a better dividend investment in 2026?

MRSN currently yields 6.88% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: XYLD offers higher current income.

What is the dividend yield difference between MRSN and XYLD?

MRSN has a forward dividend yield of 6.88% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 4.10 percentage points.

Home › Compare › MRSN vs XYLD

MRSN vs XYLD: Dividend Comparison 2026

MRSN yields 6.88% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MRSN wins by $6.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

MRSN

● Live price

6.88%

Share price

$29.08

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.5K

Annual income

$1,064.67

Full MRSN calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — MRSN vs XYLD

📍 MRSN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MRSN	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MRSN + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MRSN pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MRSN

Annual income on $10K today (after 15% tax)

$584.59/yr

After 10yr DRIP, annual income (after tax)

$904.97/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, XYLD beats the other by $1,831.20/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MRSN + XYLD for your $10,000?

MRSN: 50%XYLD: 50%

100% XYLD50/50100% MRSN

Portfolio after 10yr

$28.4K

Annual income

$2,141.85/yr

Blended yield

7.54%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRSN right now

MRSN

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$10.00

-65.6% upside vs current

Range: $3.00 — $17.00

Altman Z

-23.2

Piotroski

2/9

XYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MRSN buys

XYLD buys

No recent congressional trades found for MRSN or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMRSNXYLD

Forward yield	6.88%	10.98% ✓
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$31.5K ✓	$25.3K
Annual income after 10y	$1,064.67	$3,219.02 ✓
Total dividends collected	$8.8K	$19.6K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: MRSN vs XYLD ($10,000, DRIP)

Year	MRSN Portfolio	MRSN Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$11,388	$687.76	$10,818	$1,098.39	+$570.00 → MRSN
2	$12,917	$731.96	$11,738	$1,222.51	+$1.2K → MRSN
3	$14,597	$775.93	$12,774	$1,364.64	+$1.8K → MRSN
4	$16,438	$819.50	$13,944	$1,527.86	+$2.5K → MRSN
5	$18,451	$862.49	$15,270	$1,715.87	+$3.2K → MRSN
6	$20,648	$904.79	$16,775	$1,933.09	+$3.9K → MRSN
7	$23,039	$946.25	$18,490	$2,184.87	+$4.5K → MRSN
8	$25,639	$986.78	$20,450	$2,477.63	+$5.2K → MRSN
9	$28,460	$1,026.28	$22,697	$2,819.19	+$5.8K → MRSN
10	$31,517	$1,064.67	$25,280	$3,219.02	+$6.2K → MRSN

MRSN vs XYLD: Complete Analysis 2026

MRSN — Stock

Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen development candidate. It has a strategic research and development partnerships with Merck KGaA and Asana BioSciences, LLC for the development of ADC product candidates utilizing Fleximer. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.

Full MRSN Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this MRSN vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MRSN vs SCHD MRSN vs JEPI MRSN vs O MRSN vs KO MRSN vs MAIN MRSN vs QYLD MRSN vs JEPQ MRSN vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.